$RRACF
Rigel Resource Acquisition Corp. Stock $rracf

$rracf Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000182912623002255 Filed on March 27, 2023

Income Statement

Concept	2022 Q4	2022
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$402.4K	$1.395M
YoY Change	-2.82%	236.79%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$402.4K	$1.395M
YoY Change	60.15%	236.79%
Operating Profit
YoY Change
Interest Expense	$6.205M	$17.61M
YoY Change	-59.64%	14.54%
% of Operating Profit
Other Income/Expense, Net	-$1.460K	$17.67M
YoY Change	-99.85%	-1893.0%
Pretax Income	$5.801M	$16.28M
YoY Change	-58.97%	16.49%
Income Tax
% Of Pretax Income
Net Earnings	$5.801M	$16.28M
YoY Change	-58.97%	16.49%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.15	$0.43
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$109.6K	$109.6K
YoY Change	-93.46%	-93.46%
Cash & Equivalents	$109.6K
Short-Term Investments
Other Short-Term Assets		$481.6K
YoY Change		-19.54%
Inventory
Prepaid Expenses	$481.6K
Receivables
Other Receivables
Total Short-Term Assets	$591.2K	$591.2K
YoY Change	-74.0%	-74.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$310.5M	$310.5M
YoY Change	1.47%	1.47%
Other Assets
YoY Change
Total Long-Term Assets	$310.5M	$310.5M
YoY Change	1.3%	1.3%
TOTAL ASSETS
Total Short-Term Assets	$591.2K	$591.2K
Total Long-Term Assets	$310.5M	$310.5M
Total Assets	$311.1M	$311.1M
YoY Change	0.75%	0.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$405.9K	$405.9K
YoY Change	-65.38%	-65.38%
Accrued Expenses	$393.3K	$393.3K
YoY Change	-51.12%	-51.12%
Deferred Revenue
YoY Change
Short-Term Debt	$236.3K	$236.3K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.135M	$1.135M
YoY Change	-42.58%	-42.58%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$15.45M	$15.45M
YoY Change	-45.94%	-45.94%
Total Long-Term Liabilities	$15.45M	$15.45M
YoY Change	-45.94%	-45.94%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.135M	$1.135M
Total Long-Term Liabilities	$15.45M	$15.45M
Total Liabilities	$16.58M	$16.58M
YoY Change	-45.72%	-45.72%
SHAREHOLDERS EQUITY
Retained Earnings	-$15.99M
YoY Change	-42.45%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$15.99M	$294.5M
YoY Change
Total Liabilities & Shareholders Equity	$311.1M	$311.1M
YoY Change	0.75%	0.75%

Cashflow Statement

Concept	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$5.801M	$16.28M
YoY Change	-58.97%	16.49%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$146.2K	-$1.554M
YoY Change	166.6%	2168.86%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	99.72K	-$11.61K
YoY Change	-99.97%	-100.0%
NET CHANGE
Cash From Operating Activities	-146.2K	-$1.554M
Cash From Investing Activities
Cash From Financing Activities	99.72K	-$11.61K
Net Change In Cash	-46.51K	-$1.566M
YoY Change	-102.96%	-193.46%
FREE CASH FLOW
Cash From Operating Activities	-$146.2K	-$1.554M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001860879
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent		usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2021Q4	rrac	Advances From Related Parties AdvancesFromRelatedParties		usd
CY2021Q4	us-gaap	Convertible Debt ConvertibleDebt		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022	rrac	Transaction Costs Allocable To Warrant Liability Overallotment Liability And Forward Purchase Agreement TransactionCostsAllocableToWarrantLiabilityOverallotmentLiabilityAndForwardPurchaseAgreement		usd
CY2022	rrac	Fair Value Of Private Warrants And Forward Purchase Agreement In Excess Of Proceeds Received FairValueOfPrivateWarrantsAndForwardPurchaseAgreementInExcessOfProceedsReceived		usd
CY2022	rrac	Gain On Unexercised Overallotment Option GainOnUnexercisedOverallotmentOption		usd
	rrac	Change In Fair Value Of Convertible Note Payable Related Party ChangeInFairValueOfConvertibleNotePayableRelatedParty		usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity		usd
	rrac	Forfeiture Of Class B Ordinary Shares Upon Expiration Of Overallotment Option ForfeitureOfClassBOrdinarySharesUponExpirationOfOverallotmentOption		usd
	rrac	Change In Fair Value Of Convertible Promissory Note Related Party ChangeInFairValueOfConvertiblePromissoryNoteRelatedParty		usd
CY2022	rrac	Gain On Unexercised Overallotment Option GainOnUnexercisedOverallotmentOption		usd
CY2022	rrac	Fair Value Of Private Warrants And Forward Purchase Agreement In Excess Of Proceeds Received FairValueOfPrivateWarrantsAndForwardPurchaseAgreementInExcessOfProceedsReceived		usd
CY2022	rrac	Transaction Costs Allocable To Warrant Liabilities TransactionCostsAllocableToWarrantLiabilities		usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022	rrac	Cash Deposited Into Trust Account CashDepositedIntoTrustAccount		usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2022	rrac	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable		usd
CY2022	rrac	Offering Costs Included In Accrued Offering Costs OfferingCostsIncludedInAccruedOfferingCosts		usd
CY2022	rrac	Class Ordinary Shares Remeasurement Adjustment ClassOrdinarySharesRemeasurementAdjustment		usd
CY2021Q4	us-gaap	Convertible Debt ConvertibleDebt		usd
CY2021Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41022
CY2022	dei	Entity Registrant Name EntityRegistrantName	Rigel Resource Acquisition Corp.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1594226
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	7 Bryant Park
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	1045 Avenue of the Americas
CY2022	dei	Entity Address Address Line3 EntityAddressAddressLine3	Floor 25
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10018
CY2022	dei	City Area Code CityAreaCode	646
CY2022	dei	Local Phone Number LocalPhoneNumber	453-2672
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Entity Shell Company EntityShellCompany	true
CY2022Q2	dei	Entity Public Float EntityPublicFloat	298200000	usd
CY2022	dei	Auditor Firm AuditorFirmId	688
CY2022	dei	Auditor Name AuditorName	Marcum llp
CY2022	dei	Auditor Location AuditorLocation	Los Angeles, CA
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	109595	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1675601	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	481630	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	26022	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	572539	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	591225	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	2274162	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	489807	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	310488798	usd
CY2021Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	306003656	usd
CY2022Q4	us-gaap	Assets Assets	311080023	usd
CY2021Q4	us-gaap	Assets Assets	308767625	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	405882	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1172307	usd
CY2022Q4	rrac	Accrued Offering Costs AccruedOfferingCosts	393324	usd
CY2021Q4	rrac	Accrued Offering Costs AccruedOfferingCosts	804655	usd
CY2022Q4	rrac	Advances From Related Parties AdvancesFromRelatedParties	99722	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	236300	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1135228	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1976962	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	4945845	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	18070221	usd
CY2022Q4	rrac	Deferred Underwriting Commission DeferredUnderwritingCommission	10500000	usd
CY2021Q4	rrac	Deferred Underwriting Commission DeferredUnderwritingCommission	10500000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	16581073	usd
CY2021Q4	us-gaap	Liabilities Liabilities	30547183	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	310488798	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	306003656	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15990598	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27783964	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-15989848	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-27783214	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	311080023	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	308767625	usd
CY2022	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	120000	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	17500	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1274710	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	396620	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1394710	usd
	us-gaap	Operating Expenses OperatingExpenses	414120	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	4485142	usd
	us-gaap	Interest Income Other InterestIncomeOther	3684	usd
	rrac	Transaction Costs Allocable To Warrant Liability Overallotment Liability And Forward Purchase Agreement TransactionCostsAllocableToWarrantLiabilityOverallotmentLiabilityAndForwardPurchaseAgreement	1213459	usd
	rrac	Fair Value Of Private Warrants And Forward Purchase Agreement In Excess Of Proceeds Received FairValueOfPrivateWarrantsAndForwardPurchaseAgreementInExcessOfProceedsReceived	4597701	usd
	rrac	Gain On Unexercised Overallotment Option GainOnUnexercisedOverallotmentOption	-227783	usd
CY2022	rrac	Change In Fair Value Of Convertible Note Payable Related Party ChangeInFairValueOfConvertibleNotePayableRelatedParty	-63700	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	13124376	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	19967480	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	17673218	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	14387787	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	16278508	usd
	us-gaap	Net Income Loss NetIncomeLoss	13973667	usd
CY2022	rrac	Weighted Average Number Of Class Ordinary Shares Outstanding Basic And Diluted WeightedAverageNumberOfClassOrdinarySharesOutstandingBasicAndDiluted	30000000	shares
	rrac	Weighted Average Number Of Class Ordinary Shares Outstanding Basic And Diluted WeightedAverageNumberOfClassOrdinarySharesOutstandingBasicAndDiluted	5799257	shares
CY2022	rrac	Basic And Diluted Net Income Per Class Ordinary Share BasicAndDilutedNetIncomePerClassOrdinaryShare	0.43
	rrac	Basic And Diluted Net Income Per Class Ordinary Share BasicAndDilutedNetIncomePerClassOrdinaryShare	1.07
CY2022	rrac	Weighted Average Number Of Class B Ordinary Shares Outstanding Basic And Diluted WeightedAverageNumberOfClassBOrdinarySharesOutstandingBasicAndDiluted	7500000	shares
	rrac	Weighted Average Number Of Class B Ordinary Shares Outstanding Basic And Diluted WeightedAverageNumberOfClassBOrdinarySharesOutstandingBasicAndDiluted	7315869	shares
CY2022	rrac	Basic And Diluted Net Income Per Class B Ordinary Share BasicAndDilutedNetIncomePerClassBOrdinaryShare	0.43
	rrac	Basic And Diluted Net Income Per Class B Ordinary Share BasicAndDilutedNetIncomePerClassBOrdinaryShare	1.07
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25000	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	261646	usd
	rrac	Remeasurement Adjustment Of Class Ordinary Shares To Redemption Value RemeasurementAdjustmentOfClassOrdinarySharesToRedemptionValue	-42039871	usd
	us-gaap	Accretion Expense AccretionExpense	3656	usd
	us-gaap	Profit Loss ProfitLoss	13973667	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-27783214	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	4485142	usd
CY2022	us-gaap	Profit Loss ProfitLoss	16278508	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-15989848	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	16278508	usd
	us-gaap	Net Income Loss NetIncomeLoss	13973667	usd
CY2022	rrac	Investment Income Earned On Investments Held In Trust Account InvestmentIncomeEarnedOnInvestmentsHeldInTrustAccount	4485142	usd
	rrac	Investment Income Earned On Investments Held In Trust Account InvestmentIncomeEarnedOnInvestmentsHeldInTrustAccount	3656	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	13124376	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	19967480	usd
CY2022	rrac	Change In Fair Value Of Convertible Promissory Note Related Party ChangeInFairValueOfConvertiblePromissoryNoteRelatedParty	63700	usd
	rrac	Gain On Unexercised Overallotment Option GainOnUnexercisedOverallotmentOption	-227783	usd
	rrac	Fair Value Of Private Warrants And Forward Purchase Agreement In Excess Of Proceeds Received FairValueOfPrivateWarrantsAndForwardPurchaseAgreementInExcessOfProceedsReceived	4597701	usd
	rrac	Transaction Costs Allocable To Warrant Liabilities TransactionCostsAllocableToWarrantLiabilities	1213459	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	261646	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	455608	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	26022	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-572539	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	572539	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-489807	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	489807	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-766425	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1172307	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1554397	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-68507	usd
	rrac	Cash Deposited Into Trust Account CashDepositedIntoTrustAccount	306000000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-306000000	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	294000000	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	14000000	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	99722	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	238405	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	238405	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	300000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25000	usd
CY2022	rrac	Payment Of Offering Costs PaymentOfOfferingCosts	411331	usd
	rrac	Payment Of Offering Costs PaymentOfOfferingCosts	280892	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-11609	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	307744108	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1566006	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1675601	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1675601	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	109595	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1675601	usd
	rrac	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	10500000	usd
	rrac	Offering Costs Included In Accrued Offering Costs OfferingCostsIncludedInAccruedOfferingCosts	804655	usd
	rrac	Class Ordinary Shares Remeasurement Adjustment ClassOrdinarySharesRemeasurementAdjustment	42039871	usd
CY2022	rrac	Current Period Accretion To Redemption Value CurrentPeriodAccretionToRedemptionValue	4485142	usd
	rrac	Current Period Accretion To Redemption Value CurrentPeriodAccretionToRedemptionValue	3656	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_805_eus-gaap--NatureOfOperations_zGASCoBg0809" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1.</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_822_zsnFyCK2E3Na">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rigel Resource Acquisition Corp. (the “Company”) was incorporated in the Cayman Islands on April 6, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All activity for the period from April 6, 2021 (inception) through December 31, 2022 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and the search for a target company. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 9, 2021, the Company consummated the Initial Public Offering of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211101__20211109__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Stock issued during period shares issued in initial public offering">27,500,000</span> units (“Units” and, with respect to the ordinary shares included in the Units which were offered, the “Public Shares”), generating gross proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20211101__20211109__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Gross proceeds from issuance of initial public offering">275,000,000</span>, which is described in Note 3.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously with the closing of the Initial Public Offering, the Company consummated the private sale (the “Private Placement”) of an aggregate of <span id="xdx_907_ecustom--ClassOfWarrantsAndRightsIssuedDuringThePeriod_c20211101__20211109__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_pdd" title="Class of warrants and rights issued during the period">14,000,000</span> warrants (the “Private Placement Warrants”) - <span id="xdx_909_ecustom--ClassOfWarrantsAndRightsIssuedDuringThePeriod_c20211101__20211109__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SposorMember_pdd" title="Class of warrants and rights issued during the period">11,300,000</span> to Rigel Resource Acquisition Holding LLC (the “Sponsor”), <span id="xdx_909_ecustom--ClassOfWarrantsAndRightsIssuedDuringThePeriod_c20211101__20211109__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NathanaelAbebeMember_pdd" title="Class of warrants and rights issued during the period">100,000</span> to Nathanael Abebe, <span id="xdx_903_ecustom--ClassOfWarrantsAndRightsIssuedDuringThePeriod_c20211101__20211109__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChristineCoignardMember_pdd" title="Class of warrants and rights issued during the period">35,000</span> to Christine Coignard, <span id="xdx_90B_ecustom--ClassOfWarrantsAndRightsIssuedDuringThePeriod_c20211101__20211109__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--KelvinDushniskyMember_pdd" title="Class of warrants and rights issued during the period">25,000</span> to Kelvin Dushnisky, <span id="xdx_906_ecustom--ClassOfWarrantsAndRightsIssuedDuringThePeriod_c20211101__20211109__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LPeterOHaganMember_pdd" title="Class of warrants and rights issued during the period">200,000</span> to L. Peter O’Hagan and <span id="xdx_907_ecustom--ClassOfWarrantsAndRightsIssuedDuringThePeriod_c20211101__20211109__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OrionMineFinanceGPMember_pdd" title="Class of warrants and rights issued during the period">2,340,000</span> to Orion Mine Finance GP III LP (“Orion GP”) - at a purchase price of $<span id="xdx_90B_ecustom--ClassOfWarrantsAndRightsIssuedPricePerWarrant_c20211101__20211109__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_pdd" title="Class of warrants and rights issued, price per warrant">1.00</span> per Private Placement Warrant, generating gross proceeds to the Company in the amount of $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20211101__20211109__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_pp0p0" title="Gross proceeds from private placement issue">14,000,000</span>, which is described in Note 4.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 9, 2021, the underwriter purchased an additional <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211101__20211109__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pdd" title="Stock issued during period shares issued in initial public offering">2,500,000</span> Units pursuant to a partial exercise of the over-allotment option. The Units were sold at an offering price of $10.00 per Unit, generating additional gross proceeds to the Company of $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20211101__20211109__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pp0p0" title="Gross proceeds from issuance of initial public offering">25,000,000</span>. Since the underwriter did not exercise the remainder of the over-allotment option, the Sponsor forfeited <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_c20211101__20211109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_pdd" title="Shares subject to forfeiture">406,250</span> Founder Shares upon the expiration of the over-allotment option in December 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of November 9, 2021, transaction costs amounted to $<span id="xdx_902_ecustom--TransactionCostsInConnectionWithInitialPublicOffering_c20211101__20211109__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Transaction costs">17,585,547</span> consisting of $<span id="xdx_904_ecustom--UnderwritingFees_c20211101__20211109__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Underwriting fees">6,000,000</span> of underwriting fees in cash, $10,500,000 of deferred underwriting fees payable (which are held in a trust account with Continental Stock Transfer & Trust Company acting as trustee (the “Trust Account”)) and $<span id="xdx_906_ecustom--CostsRelatedToInitialPublicOffering_c20211101__20211109__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Costs related to Initial Public Offering">1,085,547</span> of costs related to the Initial Public Offering. Cash of $109,595 was held outside of the Trust Account on December 31, 2022 and was available for working capital purposes. As described in Note 6, the $<span id="xdx_902_ecustom--DeferredUnderwritingFees_c20211109__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Deferred underwriting fees">10,500,000</span> deferred underwriting fees are contingent upon the consummation of the Business Combination by May 9, 2023 or November 9, 2023 if an extension option is elected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following the closing of the Initial Public Offering on November 9, 2021, an amount of $<span id="xdx_909_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20211101__20211109__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Sale of stock">306,000,000</span> ($<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_c20211109__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Share Price">10.20</span> per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement was placed in Trust Account which may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the Trust Account, as described below.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations with one or more operating businesses or assets with a fair market value equal to at least <span id="xdx_903_ecustom--ProspectiveAssetsOfAcquireeAsAPercentageOfFairValueOfAssetsInTheTrustAccount_iI_dp_c20221231_zBU8xLE6P0Ye" title="Prospective assets of acquiree as a percentage of fair value of assets in the trust account">80</span>% of the value of the net assets held in the Trust Account (as defined above) (excluding the deferred underwriting commissions). The Company will only complete a Business Combination if the post transaction company owns or acquires <span id="xdx_908_ecustom--EquityMethodsInvestmentOwnershipPercentage_iI_dp_c20221231_z5abKVcZQri1" title="Equity method investment ownership percentage">50</span>% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will provide the holders of the outstanding Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer in connection with the Business Combination. The decision as to whether the Company will seek shareholder approval for a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $<span id="xdx_90F_ecustom--PerShareValueOfRestrictedAssets_c20221231_pdd" title="Per Share Value Of Restricted Assets">10.20</span> per Public Share, and such amount will be increased by $0.10 per public share for any three-month extension of our time to consummate our initial Business Combination, as described herein, plus any pro rata interest then in the Trust Account). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Public Shares subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Accounting Standards Codification (“ASC”) Topic 480 “<i>Distinguishing Liabilities from Equity</i>.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Company seeks shareholder approval of the Business Combination, the Company will proceed with a Business Combination only if the Company receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company, or such other vote as required by law or stock exchange rule. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (the “SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding the foregoing, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares without the Company’s prior written consent.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The holders of the Founder Shares have agreed (a) to waive their redemption rights with respect to any Founder Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial Business Combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Company has not completed a Business Combination within 18 months (or up to 24 months, if applicable) from the closing of the Initial Public Offering (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (less up to $<span id="xdx_907_ecustom--DissolutionExpenses_c20220101__20221231_pp0p0" title="Dissolution expenses">100,000</span> of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The holders of the Founder Shares have agreed to waive the rights to liquidating distributions from the Trust Account with respect to the Founder Shares they will receive if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or any of its respective affiliates acquire Public Shares, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriter has agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period, and in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.20 or $10.30 or $10.40 in case of one or both extensions of the time period to complete our initial Business Combination have been effectuated).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.20 per Public Share following the closing of the Initial Public Offering, $10.30 per public share after 18 months from the closing of the Initial Public Offering, or $10.40 per public share after 21 months from the closing of the Initial Public Offering, as applicable; and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.20 per Public Share, due to reductions in the value of trust assets. This liability will not apply to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and as to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Going Concern Considerations</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has incurred and expects to continue to incur significant costs in pursuit of its acquisition plans. In addition, the Company currently has less than 12 months from the date these financial statements were issued to complete a Business Combination transaction. If the Company is unsuccessful in consummating an initial Business Combination within 18 months from the closing of the Initial Public Offering (May 9, 2023), per the mandatory liquidation requirement, the Company must cease all operations, redeem the Public Shares and thereafter liquidate and dissolve. In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, <i>“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” </i>the Company does not have adequate liquidity to sustain operations. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the financial statements are issued. There is no assurance that the Company’s plans to raise capital or to consummate a Business Combination will be successful or successful within the Combination Period. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks and Uncertainties</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management is currently evaluating the impact of the COVID-19 pandemic and other events (such as the invasion by Russia of Ukraine and any further escalation of hostilities related thereto, terrorist attacks, natural disasters or a significant outbreak of other infectious diseases), on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p>
CY2022Q4	rrac	Prospective Assets Of Acquiree As A Percentage Of Fair Value Of Assets In The Trust Account ProspectiveAssetsOfAcquireeAsAPercentageOfFairValueOfAssetsInTheTrustAccount	0.80	pure
CY2022Q4	rrac	Equity Methods Investment Ownership Percentage EquityMethodsInvestmentOwnershipPercentage	0.50	pure
CY2022Q4	rrac	Per Share Value Of Restricted Assets PerShareValueOfRestrictedAssets	10.20
CY2022	rrac	Dissolution Expenses DissolutionExpenses	100000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_zmW4ZYe2lHR" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zwPFVoIBvaYd">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. The Company’s significant estimates and assumptions include the fair value of the related party convertible note and the change in fair value of the derivative liabilities. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates. Although the Company believes that its estimates and assumptions are reasonable, they are based upon information available at the time the estimates and assumptions were made. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	310500000	usd
CY2021Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	306000000.0	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	310500000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	306000000	usd
CY2022	rrac	Warrant Exercisable WarrantExercisable	15000000	shares
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_zBRO4LDPi5qk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zOtsgdmsDx32">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal depository insurance coverage of $<span id="xdx_90B_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20221231_zuTHneBoe1Pi" title="Federal Depository Insurance Corporation">250,000</span>. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p id="xdx_84C_eus-gaap--DerivativesReportingOfDerivativeActivity_zwOA2s3Vzhs2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zcxlYLrNvLa1">Derivative Financial Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “<i>Derivatives and Hedging</i>.” The Company’s derivative instruments are recorded at fair value as of the closing date of the Initial Public Offering (November 9, 2021) and re-valued at each reporting date, with changes in the fair value reported in the statements of operations. Derivative assets and liabilities are classified on the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Company has determined the public warrants, the Private Placement Warrants and the Forward Purchase Agreement are derivative instruments. As the public warrants, the Private Placement Warrants and the Forward Purchase Agreement meet the definition of a derivative, the public warrants, the Private Placement Warrants and Forward Purchase Agreement are measured at fair value at issuance and at each reporting date in accordance with ASC 820, <i>Fair Value Measurement</i>, with changes in fair value recognized in the statements of operations in the period of change.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	236300	usd
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	4945845	usd
CY2021Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	18070221	usd
CY2022	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	120000	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	17500	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	236300	usd
CY2022	rrac	Change In Fair Value Of Convertible Note Payable Related Party ChangeInFairValueOfConvertibleNotePayableRelatedParty	-63700	usd
CY2022Q4	rrac	Accrued Legal Fees AccruedLegalFees	378300	usd
CY2022Q4	rrac	Accrued Offering Cost AccruedOfferingCost	378300	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	206000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022	rrac	Class Of Warrants Or Rights Issued During The Period ClassOfWarrantsOrRightsIssuedDuringThePeriod	29000000	shares
CY2022Q4	us-gaap	Extended Product Warranty Accrual Current ExtendedProductWarrantyAccrualCurrent	37584000	usd
	rrac	Initial Measurement InitialMeasurement	38265484	usd
	rrac	Change In Fair Value ChangeInFairValue	-19967480	usd
	rrac	Gain On Unexercised Overallotment Option GainOnUnexercisedOverallotmentOption	-227783	usd
CY2021Q4	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	18070221	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	300000	usd
CY2022	rrac	Change In Fair Value ChangeInFairValue	-13188076	usd
CY2022Q4	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	5182145	usd

Files In Submission

Name	View Source	Status
0001829126-23-002255-index-headers.html	Edgar Link	pending
0001829126-23-002255-index.html	Edgar Link	pending
0001829126-23-002255.txt	Edgar Link	pending
0001829126-23-002255-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rigelresources_10k.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
rigelresources_ex31-1.htm	Edgar Link	pending
rigelresources_ex31-2.htm	Edgar Link	pending
rigelresources_ex32-1.htm	Edgar Link	pending
rigelresources_ex32-2.htm	Edgar Link	pending
rrac-20221231.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
rrac-20221231_cal.xml	Edgar Link	unprocessable
rrac-20221231_def.xml	Edgar Link	unprocessable
rrac-20221231_lab.xml	Edgar Link	unprocessable
rrac-20221231_pre.xml	Edgar Link	unprocessable
rigelresources_10k_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RRACF
Rigel Resource Acquisition Corp. Stock $rracf

2022 Q4 Form 10-K Financial Statement

#000182912623002255 Filed on March 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RRACF Rigel Resource Acquisition Corp. Stock $rracf

2022 Q4 Form 10-K Financial Statement

#000182912623002255 Filed on March 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RRACF
Rigel Resource Acquisition Corp. Stock $rracf